Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

PaperCitations, authors & open-access status

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 641 citations, 2011 year and closed oa status.

641
Citations
2011
Year
closed
OA Status

Related on ScholarIQ

Peter Vajkoczy
Author
Intracranial Aneurysms: Treatment and Complications
Topic
Intracranial Aneurysms: Treatment and Complications
Topic
Intracerebral and Subarachnoid Hemorrhage Research
Topic
Takotsubo Cardiomyopathy and Associated Phenomena
Topic
470M+ articles · free account